Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
6.74 EUR | -0.30% | -5.60% | +58.22% |
07-01 | Nyxoah Submits Final Module of Premarket Approval Application for Sleep Apnea Therapy to FDA | MT |
07-01 | Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.22% | 249M | |
+2.06% | 207B | |
+5.69% | 181B | |
+29.31% | 155B | |
+1.56% | 64.42B | |
+18.36% | 54.38B | |
-1.92% | 47.43B | |
-8.37% | 37.17B | |
-1.37% | 34.81B | |
+8.67% | 27.46B |
- Stock Market
- Equities
- NYXH Stock
- News Nyxoah SA
- Stifel Nicolaus Adjusts Nyxoah Price Target to $16 From $19, Maintains Buy Rating